RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical ...

The Clinical Trials Arena team investigates the impact of government-led research funding cuts in clinical trials.

PNC Financial Services Group Inc. lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 8.9 ...

CorMedix today reports its second full quarter of DefenCath sales since commencing outpatient launch in July 2024 and first partial year of DefenCath sales. The Company reported net sales of $31.2 ...

Equities researchers at Zacks Research cut their Q1 2025 earnings estimates for Theravance Biopharma in a research note ...

Benitec Biopharma (NASDAQ:BNTC) is looking to raise around $30M in gross proceeds via its securities offerings. The biotechnology company is selling 1,443,000 shares of its common stock (or pre-funded ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.76%, which has investors questioning if this is right time to sell.

Fortunately, the S&P 500 recovered to new all-time highs by August 2020 and is now up about 150% from its COVID lows.

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

Biotech firm Atai is the latest publicly traded company to announce a Bitcoin treasury strategy, starting with a $5 million ...

Samsung E&A (Seoul, South Korea) has won a contract for the main construction of the Songdo Bio Raw Materials Plant from ...